Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • krobison
    Senior Member
    • Nov 2007
    • 734

    #1

    Computational Biologist, Microbial Genome Assembly

    Warp Drive Bio is looking for a computational biologist to join our team in Cambridge MA. WDB is committed to discovering innovative natural product drugs to treat serious unmet medical needs and is backed by significant funding from Sanofi, Greylock Ventures and Third Rock Ventures.

    The ideal candidate for this position would have significant experience in de novo bacterial genome assembly and scaffolding from Illumina and other high-throughput sequencing platforms, as well as familiarity with tools to pre-process reads in FASTQ format. Experience programming in Perl or Python as well as writing complex SQL queries is also required. Prior experience with Sun Grid Engine would be highly valuable. The ability to report scientific findings clearly and concisely with appropriate analysis and presentation of data is critical.

    Information on applying for this position can be found on the Warp Drive Bio website. Interested individuals are also encouraged to contact me by private message.
    Last edited by krobison; 12-06-2012, 05:35 AM.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    Yesterday, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 10:52 AM
0 responses
8 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 05:39 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Working...